Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML
ClinicalTrials.gov study NCT03504410. IPD Sharing: NO. Countries: 9. Publications: 1.
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS
ClinicalTrials.gov study NCT01300572. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment
ClinicalTrials.gov study NCT00632749. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML
ClinicalTrials.gov study NCT02944162. IPD Sharing: YES. Countries: 1. Publications: 1.
Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML
ClinicalTrials.gov study NCT01883362. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
ClinicalTrials.gov study NCT01861002. IPD Sharing: NO. Countries: 3. Publications: 1.
Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01898793. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01829503. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01289457. IPD Sharing: Not stated. Countries: 1. Publications: 1.
AflacLL1901 (CHOA-AML)
ClinicalTrials.gov study NCT04326439. IPD Sharing: NO. Countries: 1. Publications: 1.
Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01786343. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
ClinicalTrials.gov study NCT00317642. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Selinexor (KPT-330) in Older Patients With Relapsed AML
ClinicalTrials.gov study NCT02088541. IPD Sharing: YES. Countries: 11. Publications: 1.
Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
ClinicalTrials.gov study NCT03306264. IPD Sharing: NO. Countries: 10. Publications: 1.
QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
ClinicalTrials.gov study NCT03050216. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT02588092. IPD Sharing: NO. Countries: 1. Publications: 1.
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
ClinicalTrials.gov study NCT02367456. IPD Sharing: NO. Countries: 6. Publications: 1.
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML
ClinicalTrials.gov study NCT01191801. IPD Sharing: YES. Countries: 15. Publications: 1.
Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
ClinicalTrials.gov study NCT02539459. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Sy
ClinicalTrials.gov study NCT01835587. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.